
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $374.4M | -- | -- | $0.81 | -- |
08/08/2025 | Q2 | $349.4M | -- | -- | $0.85 | -- |
05/28/2025 | Q1 | $326.7M | $332.6M | $0.49 | $0.72 | -$0.23 |
02/06/2025 | Q4 | $330.4M | $355.3M | $0.30 | $0.76 | -$0.46 |
11/06/2024 | Q3 | $289.5M | $301.1M | $0.33 | $0.43 | -$0.10 |
08/08/2024 | Q2 | $304.3M | $324.5M | $0.81 | $0.85 | -$0.04 |
05/22/2024 | Q1 | $292.4M | $321.1M | $0.25 | $0.33 | -$0.08 |
02/06/2024 | Q4 | $238.9M | $270.9M | $0.46 | $0.56 | -$0.10 |
11/01/2023 | Q3 | -- | -- | $0.58 | $0.53 | $0.05 |
08/01/2023 | Q2 | -- | -- | $0.93 | $0.57 | $0.36 |
05/24/2023 | Q1 | -- | -- | $0.29 | $0.20 | $0.09 |
02/01/2023 | Q4 | -- | -- | $0.34 | $0.23 | $0.11 |
11/02/2022 | Q3 | -- | -- | $0.21 | $0.16 | $0.05 |
08/03/2022 | Q2 | -- | -- | $0.27 | $0.24 | $0.03 |
05/25/2022 | Q1 | -- | -- | $0.03 | $0.06 | -$0.03 |
02/02/2022 | Q4 | -- | -- | $0.12 | $0.15 | -$0.03 |
11/03/2021 | Q3 | -- | -- | $0.11 | $0.12 | -$0.01 |
08/04/2021 | Q2 | -- | -- | $0.15 | $0.14 | $0.01 |
05/26/2021 | Q1 | -- | -- | -$0.00 | $0.09 | -$0.09 |
02/03/2021 | Q4 | -- | -- | $0.08 | $0.24 | -$0.16 |
11/04/2020 | Q3 | -- | -- | $0.01 | $0.13 | -$0.12 |
08/05/2020 | Q2 | -- | -- | $0.03 | $0.04 | -$0.01 |
05/21/2020 | Q1 | -- | -- | -$0.01 | $0.05 | -$0.06 |
02/05/2020 | Q4 | -- | -- | $0.16 | $0.15 | $0.01 |
11/06/2019 | Q3 | -- | -- | $0.13 | $0.09 | $0.04 |
08/07/2019 | Q2 | -- | -- | $0.07 | $0.06 | $0.01 |
05/08/2019 | Q1 | -- | -- | -$0.37 | $0.06 | -$0.43 |
02/26/2019 | Q4 | -- | -- | $0.20 | $0.21 | -$0.01 |
11/05/2018 | Q3 | -- | -- | $0.08 | -- | -- |
08/08/2018 | Q2 | -- | -- | $0.03 | -- | -- |
05/09/2018 | Q1 | -- | -- | $0.01 | -- | -- |
02/27/2018 | Q4 | -- | -- | $0.44 | -- | -- |
11/08/2017 | Q3 | -- | -- | $0.12 | -- | -- |
08/09/2017 | Q2 | -- | -- | $0.08 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.04 | -- | -- |
03/08/2017 | Q4 | -- | -- | $0.13 | -- | -- |
11/10/2016 | Q3 | -- | -- | -$73.13 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$2.17 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.81 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.95 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.11 | -- | -- |
e.l.f. Beauty reported $332.6M worth of top line sales in its most recent quarter.
e.l.f. Beauty announced earnings per share of $0.49 which represents a miss of analyst forecast a $0.72 per share.
e.l.f. Beauty reported $237M that represents $4.09 per share over the last quarter.
e.l.f. Beauty's earnings are forecast to grow from $1.92 per share to $3.32 per share next year representing an increase of 88.63%.
e.l.f. Beauty's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.